Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation (Q45111033)

9 December 2017

Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation (English)

1 reference

9 December 2017

1 reference

1 reference

Guillermina Girardi

1

0 references

author name string

Patricia Redecha

series ordinal

2

1 reference

9 December 2017

Jane E Salmon

series ordinal

3

1 reference

9 December 2017

language of work or name

English

0 references

publication date

17 October 2004

1 reference

9 December 2017

1 reference

9 December 2017

10

1 reference

9 December 2017

1222-1226

1 reference

9 December 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1121

9 December 2017

0 references

cites work

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

1 reference

Validation of the Sapporo criteria for antiphospholipid syndrome

21 January 2018

1 reference

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies

21 January 2018

1 reference

Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

21 January 2018

1 reference

Complement C3 activation is required for antiphospholipid antibody-induced fetal loss

21 January 2018

1 reference

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome

21 January 2018

1 reference

Management of the obstetric antiphospholipid syndrome

21 January 2018

1 reference

Placental pathology in systemic lupus erythematosus: a prospective study.

21 January 2018

1 reference

Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin

21 January 2018

1 reference

Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase

21 January 2018

1 reference

Heparin and derivatized heparin inhibit zymosan and cobra venom factor activation of complement in serum

21 January 2018

1 reference

Inhibition of complement-mediated haemolysis in paroxysmal nocturnal haemoglobinuria by heparin or low-molecular weight heparin.

21 January 2018

1 reference

Heparin and low-dose aspirin restore placental human chorionic gonadotrophin secretion abolished by antiphospholipid antibody-containing sera.

21 January 2018

1 reference

Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome.

21 January 2018

1 reference

Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents

21 January 2018

1 reference

Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins

21 January 2018

1 reference

Heparan sulfate proteoglycans in glomerular inflammation.

21 January 2018

1 reference

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

21 January 2018

1 reference

New heparin dosing recommendations for patients with acute coronary syndromes

21 January 2018

1 reference

Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice.

21 January 2018

1 reference

Fc gamma receptor IIIb enhances Fc gamma receptor IIa function in an oxidant-dependent and allele-sensitive manner

21 January 2018

1 reference

Disruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality.

21 January 2018

1 reference

Regulation of interleukin-6 fetoplacental levels could be involved in the protective effect of low-molecular weight heparin treatment on murine spontaneous abortion

21 January 2018

1 reference

The role of placental trophoblast in the pathophysiology of the antiphospholipid antibody syndrome

21 January 2018

1 reference

The antiphospholipid syndrome

21 January 2018

1 reference

7 January 2021

Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss

1 reference

7 January 2021

Placental thrombosis and fetal loss after passive transfer of mouse lupus monoclonal or human polyclonal anti-cardiolipin antibodies in pregnant naive BALB/c mice

1 reference

7 January 2021

Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo

1 reference

7 January 2021

Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies

1 reference

7 January 2021

Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--III. Inhibition of C4 and C2 binding site(s) on C1s by polyanions

1 reference

7 January 2021

Interaction of heparin with beta 2-glycoprotein I and antiphospholipid antibodies in vitro

1 reference

7 January 2021

Effects of heparin and N-acetyl heparin on ischemia/reperfusion-induced alterations in myocardial function in the rabbit isolated heart

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1121

1 reference

Dimensions Publication ID

9 December 2017

0 references

1 reference